Aileron Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
APPLE TREE PARTNERS II LP 10 percent owner
 Common Stock 104,799 $6.29 $659,500
Sale
APPLE TREE PARTNERS II LP 10 percent owner
 Common Stock 3,105 $7.05 $21,890
Sale
APPLE TREE PARTNERS II LP 10 percent owner
 Common Stock 150,000 $9.8 $1,470,450
Purchase
SIGMA EMERGING MARKETS LTD. 10 percent owner
 Common Stock 190,000 $15 $2,850,000
Purchase
EXCEL MEDICAL FUND LP 10 percent owner
 Common Stock 60,000 $15 $900,000
Purchase
ROCHE HOLDING LTD 10 percent owner
 Common Stock 119,400 $15 $1,791,000
Purchase
AMBROS REINHARD J. director
 Common Stock 266,667 $15 $4,000,005
Purchase
SATTER MUNEER A director, officer: See Remarks
 Common Stock 33,333 $15 $499,995
Purchase
KAPNICK SCOTT director
 Common Stock 292,639 $15 $4,389,585
Purchase
AJU IB INVESTMENT CO., LTD. 10 percent owner
 Common Stock 24,929 $15 $373,935
Purchase
KCK LTD. 10 percent owner
 Common Stock 200,000 $15 $3,000,000
Purchase
CVF, LLC 10 percent owner
 Common Stock 180,000 $15 $2,700,000
Purchase
GALLAGHER BRIAN M. JR. director
 Common Stock 273,333 $15 $4,099,995
Purchase
SHANAFELT ARMEN director
 Common Stock 250,000 $15 $3,750,000
Purchase
LV MANAGEMENT GROUP, LLC other: Former 10% owner
 Common Stock 250,000 $15 $3,750,000
Purchase
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 266,667 $15 $4,000,005

Showing 100 to 116 of 116 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: